Stock Quote

ACOR (Common Stock) $ 40.05 -0.01 (-0.03%) Volume: 468,750 MORE December 22, 2014

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *






Analysts

Firm Analyst
Aegis Capital Yi Chen, Ph.D., CFA
Canaccord Genuity John Newman, Ph.D.
Citigroup Yaron Werber, M.D.
Cowen and Company Phil Nadeau, Ph.D.
FBR Capital Markets William Tanner, Ph.D.
Goldman Sachs Navdeep Singh
ISI Group Mark Schoenebaum, M.D.
MKM Partners Jon LeCroy, M.D.
Piper Jaffray Co. David Amsellem
RBC Capital Markets Michael Yee
Robert W. Baird & Co. Christopher J. Raymond
Stifel Nicolaus Thomas Shrader

Acorda Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Acorda Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Acorda Therapeutics, Inc. or its management. Acorda Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.